Patients on HER2-targeted therapies for HER2-positive metastatic breast cancer should be vigilant about potential side effects like heart toxicities and ...

Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease ...

While analysis of molecular subtypes of muscle-invasive bladder cancer using tumor RNA expression can improve the ability to predict the likelihood of ...

Patient-facing artificial intelligence (AI) has been used more in recent years; however, it may cause some ethical challenges and threats to a patient’s ...

Christine Cooper, RN, BSN, provides a preview of an upcoming CURE Expert Connections program discussing advancements in the care of myelofibrosis, including ...

Living through a war in real time has affected my life. I recently went for my three-month check-up with my oncologist and for the first time, my blood ...

For patients with cervical cancer who are negative for high-risk human papillomavirus (HPV) with normal or low-grade cytology, a prolonged follow-up ...

A recent study, with information from the National Lung Screening Trial (NLST) and Stanford Healthcare (SHC) concluded that patients with distant recurrent ...

NICE and the SMC made their decisions after consulting the results of the Phase III TOPAZ-1 trial, which showed that adding durvalumab to gemcitabine ...

You’ve just been diagnosed, and “cancer” seems to be the wallpaper of every room you enter. Treatments, discussions, opinions, and decisions are ...